Listed

Alignment Healthcare, Inc.

ALHCNasdaqCIK 1832466FinancialsFiscal year ends Dec 31

Latest reported revenue, Q3 FY2026$1.36bnRevenue, Q3 FY2026, three months to 2026-09-30$1.36bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Report this figureThree months to Sep 30, 2026, from the 10-Q filed Oct 29, 2026.

Latest quarter: Q3 FY2026

Three months to Sep 30, 2026, against the same quarter a year earlier.

  • Revenue$1.36bnRevenue, Q3 FY2026, three months to 2026-09-30$1.36bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Report this figure+36.7% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin−0.3%Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: −$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Revenue: $1.36bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Report this figure−1.1 pts on a year earlier
  • Net margin−0.6%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: −$8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Revenue: $1.36bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Report this figure−1.0 pts on a year earlier
  • Diluted EPS−$0.04Diluted EPS, Q3 FY2026, three months to 2026-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Report this figureSign changed from a year earlier
  • Free cash flow$38.6mFree cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $47.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001628280-26-068247. Derived: 9-month figure less the 6-month figure.Capital expenditure: $8.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001628280-26-068247. Derived: 9-month figure less the 6-month figure.Report this figure−72.3% on a year earlier

Last eight quarters

Full statements
Revenue$1.36bnOperating margin −0.3%
Diluted EPS−$0.04, Q3 FY2026
Free cash flow$38.6m, Q3 FY2026
Alignment Healthcare, Inc., key figures for the last eight quarters
Line itemUnitQ4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30Shape over the periods
Revenue$m701Revenue, Q4 FY2024, three months to 2024-12-31$701.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Report this figure927Revenue, Q1 FY2025, three months to 2025-03-31$926.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Report this figure1,015Revenue, Q2 FY2025, three months to 2025-06-30$1.02bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-30, accession 0001628280-26-051060.Report this figure994Revenue, Q3 FY2025, three months to 2025-09-30$993.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Report this figure1,013Revenue, Q4 FY2025, three months to 2025-12-31$1.01bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Report this figure1,235Revenue, Q1 FY2026, three months to 2026-03-31$1.24bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Report this figure1,336Revenue, Q2 FY2026, three months to 2026-06-30$1.34bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-30, accession 0001628280-26-051060.Report this figure1,358Revenue, Q3 FY2026, three months to 2026-09-30$1.36bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%(3.2%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$22.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Revenue: $701.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Report this figure(0.6%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Revenue: $926.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Report this figure2.2%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $22.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-051060.Revenue: $1.02bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-30, accession 0001628280-26-051060.Report this figure0.8%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Revenue: $993.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Report this figure(1.0%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Revenue: $1.01bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Report this figure1.3%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $15.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Revenue: $1.24bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Report this figure3.2%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $42.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-051060.Revenue: $1.34bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-30, accession 0001628280-26-051060.Report this figure(0.3%)Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: −$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Revenue: $1.36bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Report this figure
Net margin%(4.4%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$31.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Revenue: $701.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Report this figure(1.0%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Revenue: $926.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Report this figure1.5%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $15.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-051060.Revenue: $1.02bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-30, accession 0001628280-26-051060.Report this figure0.4%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $3.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Revenue: $993.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Report this figure(1.1%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$11.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Revenue: $1.01bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Report this figure0.9%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $11.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Revenue: $1.24bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Report this figure2.7%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $36.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-051060.Revenue: $1.34bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-30, accession 0001628280-26-051060.Report this figure(0.6%)Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: −$8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Revenue: $1.36bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)(0.05)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Report this figure0.07Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001628280-26-051060.Report this figure0.02Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Report this figurenot reported (Diluted EPS not reported)0.05Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Report this figure0.17Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001628280-26-051060.Report this figure(0.04)Diluted EPS, Q3 FY2026, three months to 2026-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001628280-26-068247.Report this figure
Free cash flow$m(18.0)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Capital expenditure: $9.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Report this figure8.4Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $16.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Capital expenditure: $8.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Report this figure21.1Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $29.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001628280-26-051060. Derived: 6-month figure less the 3-month figure.Capital expenditure: $8.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001628280-26-051060. Derived: 6-month figure less the 3-month figure.Report this figure139Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $144.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001628280-26-068247. Derived: 9-month figure less the 6-month figure.Capital expenditure: $5.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001628280-26-068247. Derived: 9-month figure less the 6-month figure.Report this figure(55.4)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$50.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Capital expenditure: $5.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001628280-26-012545. Derived: 12-month figure less the 9-month figure.Report this figure121Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $128.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Capital expenditure: $7.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001628280-26-028901.Report this figure(27.5)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$17.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001628280-26-051060. Derived: 6-month figure less the 3-month figure.Capital expenditure: $10.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001628280-26-051060. Derived: 6-month figure less the 3-month figure.Report this figure38.6Free cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $47.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001628280-26-068247. Derived: 9-month figure less the 6-month figure.Capital expenditure: $8.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001628280-26-068247. Derived: 9-month figure less the 6-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$3.95bnOperating margin 0.4%
Diluted EPS$0.00, FY2025
Free cash flow$113.1m, FY2025
Alignment Healthcare, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m1,167Revenue, FY2021, twelve months to 2021-12-31$1.17bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000950170-24-021154.Report this figure1,432Revenue, FY2022, twelve months to 2022-12-31$1.43bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000950170-24-021154.Report this figure1,801Revenue, FY2023, twelve months to 2023-12-31$1.80bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000950170-24-021154.Report this figure2,704Revenue, FY2024, twelve months to 2024-12-31$2.70bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001628280-26-012545.Report this figure3,949Revenue, FY2025, twelve months to 2025-12-31$3.95bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001628280-26-012545.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%(15.3%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$178.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-27, accession 0000950170-24-021154.Revenue: $1.17bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000950170-24-021154.Report this figure(9.0%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$128.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-27, accession 0001628280-25-008730.Revenue: $1.43bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000950170-24-021154.Report this figure(7.1%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$127.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001628280-26-012545.Revenue: $1.80bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000950170-24-021154.Report this figure(3.8%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$101.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001628280-26-012545.Revenue: $2.70bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001628280-26-012545.Report this figure0.4%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $14.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001628280-26-012545.Revenue: $3.95bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001628280-26-012545.Report this figure
Net margin%(16.7%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$195.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-27, accession 0000950170-24-021154.Revenue: $1.17bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000950170-24-021154.Report this figure(10.4%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$149.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-27, accession 0001628280-25-008730.Revenue: $1.43bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000950170-24-021154.Report this figure(8.2%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$148.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001628280-26-012545.Revenue: $1.80bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000950170-24-021154.Report this figure(4.7%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$128.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001628280-26-012545.Revenue: $2.70bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001628280-26-012545.Report this figure(0.0%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$724.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001628280-26-012545.Revenue: $3.95bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001628280-26-012545.Report this figure
Diluted EPS$ per share(1.14)Diluted EPS, FY2021, twelve months to 2021-12-31−$1.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-27, accession 0000950170-24-021154.Report this figure(0.83)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-27, accession 0001628280-25-008730.Report this figure(0.79)Diluted EPS, FY2023, twelve months to 2023-12-31−$0.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-27, accession 0001628280-26-012545.Report this figure(0.67)Diluted EPS, FY2024, twelve months to 2024-12-31−$0.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-27, accession 0001628280-26-012545.Report this figure0.00Diluted EPS, FY2025, twelve months to 2025-12-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-27, accession 0001628280-26-012545.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)(69.2)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$45.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-27, accession 0001628280-25-008730.Capital expenditure: $23.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-27, accession 0001628280-25-008730.Report this figure(95.2)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$59.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001628280-26-012545.Capital expenditure: $36.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001628280-26-012545.Report this figure(6.6)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $34.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001628280-26-012545.Capital expenditure: $41.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001628280-26-012545.Report this figure113Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $139.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001628280-26-012545.Capital expenditure: $26.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001628280-26-012545.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Dec 2024 to Nov 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Alignment Healthcare, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$460.6m19,342,956Added+5,267,759
WELLINGTON MANAGEMENT GROUP LLP2026-06-30$447.2m18,780,363Added+1,681,427
FMR LLC2026-06-30$331.5m13,924,329Reduced−1,967,735
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$277.9m11,672,259Added+1,962,188
Invesco Ltd.2026-06-30$246.8m10,365,640Added+3,365,541
BANK OF AMERICA CORP /DE/2026-06-30$222.5m9,346,742Added+6,131,075
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$193.9m8,144,247Added+170,584
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC2026-06-30$184.8m7,761,403Added+2,546,789
STATE STREET CORP2026-06-30$173.8m7,297,494Added+3,003,800
Hood River Capital Management LLC2026-06-30$147.3m6,184,526Added+130,049

Recent filings

All 809 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Alignment Healthcare, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-2916:15 ET10-QQuarterly reportPeriod 2026-09-300001628280-26-068247
2026-10-2916:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-26-006971
2026-10-0817:13 ET8-K7.01 Regulation FD disclosure0001628280-26-065470
2026-07-3016:14 ET10-QQuarterly reportPeriod 2026-06-300001628280-26-051060
2026-07-3016:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-26-005078
2026-06-0916:31 ET8-K5.07 Shareholder vote results0001628280-26-041926
2026-05-1216:33 ET8-K5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure0001628280-26-034147
2026-04-3016:14 ET10-QQuarterly reportPeriod 2026-03-310001628280-26-028901
2026-04-3016:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-26-002895
2026-04-2410:52 ETDEF 14AProxy statementPeriod 2026-06-040001628280-26-027058

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 27, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures.See the target

About the filer

CIK
1832466
Tickers
ALHC
Exchange
Nasdaq
SIC code
6324 Hospital & Medical Service Plans
Sector
Financials
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 18:01 ET. Listed shows no prices and gives no investment advice.